114 related articles for article (PubMed ID: 16207502)
1. Genetic variability at the LXR gene (NR1H2) may contribute to the risk of Alzheimer's disease.
Adighibe O; Arepalli S; Duckworth J; Hardy J; Wavrant-De Vrièze F
Neurobiol Aging; 2006 Oct; 27(10):1431-4. PubMed ID: 16207502
[TBL] [Abstract][Full Text] [Related]
2. Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease.
Wang B; Jin F; Xie Y; Tang Y; Kan R; Zheng C; Yang Z; Wang L
Neurosci Lett; 2006 Dec; 409(3):179-81. PubMed ID: 17027152
[TBL] [Abstract][Full Text] [Related]
3. Variations in the APP gene promoter region and risk of Alzheimer disease.
Guyant-Maréchal L; Rovelet-Lecrux A; Goumidi L; Cousin E; Hannequin D; Raux G; Penet C; Ricard S; Macé S; Amouyel P; Deleuze JF; Frebourg T; Brice A; Lambert JC; Campion D
Neurology; 2007 Feb; 68(9):684-7. PubMed ID: 17325276
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease.
Ozturk A; DeKosky ST; Kamboh MI
Neurobiol Aging; 2006 Oct; 27(10):1440-4. PubMed ID: 16223550
[TBL] [Abstract][Full Text] [Related]
5. Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases.
Li YJ; Scott WK; Zhang L; Lin PI; Oliveira SA; Skelly T; Doraiswamy MP; Welsh-Bohmer KA; Martin ER; Haines JL; Pericak-Vance MA; Vance JM
Neurobiol Aging; 2006 Aug; 27(8):1087-93. PubMed ID: 15985314
[TBL] [Abstract][Full Text] [Related]
6. Gene-gene interaction between heme oxygenase-1 and liver X receptor-beta and Alzheimer's disease risk.
Infante J; Rodríguez-Rodríguez E; Mateo I; Llorca J; Vázquez-Higuera JL; Berciano J; Combarros O
Neurobiol Aging; 2010 Apr; 31(4):710-4. PubMed ID: 18597895
[TBL] [Abstract][Full Text] [Related]
7. Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease.
Kamboh MI; Minster RL; Kenney M; Ozturk A; Desai PP; Kammerer CM; DeKosky ST
Neurobiol Aging; 2006 Oct; 27(10):1435-9. PubMed ID: 16137793
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent association of KIBRA genetic variation and Alzheimer's disease risk.
Rodríguez-Rodríguez E; Infante J; Llorca J; Mateo I; Sánchez-Quintana C; García-Gorostiaga I; Sánchez-Juan P; Berciano J; Combarros O
Neurobiol Aging; 2009 Feb; 30(2):322-4. PubMed ID: 17707552
[TBL] [Abstract][Full Text] [Related]
9. Interaction between CD14 and LXRbeta genes modulates Alzheimer's disease risk.
Rodríguez-Rodríguez E; Sánchez-Juan P; Mateo I; Infante J; Sánchez-Quintana C; García-Gorostiaga I; Berciano J; Combarros O
J Neurol Sci; 2008 Jan; 264(1-2):97-9. PubMed ID: 17900622
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
Kamboh MI
Hum Biol; 1995 Apr; 67(2):195-215. PubMed ID: 7729825
[TBL] [Abstract][Full Text] [Related]
11. Lack of genetic association of cholesteryl ester transfer protein polymorphisms with late onset Alzheimers disease.
Zhu H; Gopalraj RK; Kelly JF; Bennett DA; Estus S
Neurosci Lett; 2005 Jun 10-17; 381(1-2):36-41. PubMed ID: 15882786
[TBL] [Abstract][Full Text] [Related]
12. PIN1 promoter polymorphisms are associated with Alzheimer's disease.
Segat L; Pontillo A; Annoni G; Trabattoni D; Vergani C; Clerici M; Arosio B; Crovella S
Neurobiol Aging; 2007 Jan; 28(1):69-74. PubMed ID: 16384626
[TBL] [Abstract][Full Text] [Related]
13. Rare variant of apolipoprotein E (Arg136 -->Ser) in two normolipidemic individuals.
Hubácek JA; Adámková V; Skodová Z
Physiol Res; 2005; 54(5):573-5. PubMed ID: 15641930
[TBL] [Abstract][Full Text] [Related]
14. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.
Pericak-Vance MA; Bass MP; Yamaoka LH; Gaskell PC; Scott WK; Terwedow HA; Menold MM; Conneally PM; Small GW; Vance JM; Saunders AM; Roses AD; Haines JL
JAMA; 1997 Oct; 278(15):1237-41. PubMed ID: 9333264
[TBL] [Abstract][Full Text] [Related]
15. The LDLR locus in Alzheimer's disease: a family-based study and meta-analysis of case-control data.
Bertram L; Hsiao M; McQueen MB; Parkinson M; Mullin K; Blacker D; Tanzi RE
Neurobiol Aging; 2007 Jan; 28(1):18.e1-4. PubMed ID: 16378661
[TBL] [Abstract][Full Text] [Related]
16. Lack of association of hepatic lipase polymorphisms with late-onset Alzheimer's disease.
Zhu H; Taylor JW; Bennett DA; Younkin SG; Estus S
Neurobiol Aging; 2008 May; 29(5):793-4. PubMed ID: 17175070
[TBL] [Abstract][Full Text] [Related]
17. [Genetic aspects of Alzheimer disease].
Øksengård AR; Engedal K
Tidsskr Nor Laegeforen; 2002 Feb; 122(5):530-1. PubMed ID: 11961985
[TBL] [Abstract][Full Text] [Related]
18. [Molecular genetics of Alzheimer's disease].
Akinori M; Ryozo K
Tanpakushitsu Kakusan Koso; 2005 Dec; 50(16 Suppl):2122-7. PubMed ID: 16411440
[No Abstract] [Full Text] [Related]
19. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
[TBL] [Abstract][Full Text] [Related]
20. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F
Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
